Cancer patients across Yorkshire will soon have better access to pioneering treatments after almost three quarters of a million pounds was pledged for a new clinical trial centre.
The Yorkshire Cancer Research Centre for Early Phase Clinical Trials, based at the University of Leeds, will provide more opportunities for the region’s cancer patients to participate in innovative studies.
The region currently lags behind most areas of England in terms of premature, preventable deaths from cancer - with 554 new cases of cancer diagnosed each week. Mortality rates in people aged 75 and under, including those considered preventable, are particularly high in areas such as Hull, Doncaster and Calderdale.
Yorkshire Cancer Research, which is based in Harrogate, has provided £724,339 for the centre, which will involve scientists at the universities of Leeds, Sheffield, York, Hull and Bradford.
As well as providing better access to innovative, new cancer treatments, it is expected that the centre will increase cancer research funding into Yorkshire and develop the next generation of leading cancer researchers.
Prof Julia Brown, director of the Clinical Trials Research Unit at the University of Leeds, said the initiative represented a “significant change” in the delivery of clinical trials ad would improve and accelerate the transition of new treatments.
She said: “This is the first stage of taking ideas from the laboratory and into hospitals and helping patients.”